ketotifen has been researched along with Vascular Diseases in 2 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, L | 1 |
| Granger, DN | 1 |
2 other studies available for ketotifen and Vascular Diseases
| Article | Year |
|---|---|
Carbon monoxide yield of cigarettes.
Topics: Carbon Monoxide; Humans; Ketotifen; Oxygen; Piperidines; Smoking; Tars; Thiophenes; Vascular Disease | 1980 |
Role of mast cells in oxidized low-density lipoprotein-induced microvascular dysfunction.
Topics: Animals; Capillary Permeability; Cell Adhesion; Cell Degranulation; Cell Movement; Female; Humans; K | 1996 |